Galenica Ltd.

Galenica is a diversified group active throughout the healthcare market which, amont other things, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical services and access to data bases and sets up networks. The Galenica Group enjoys a leading position in all its areas of activity – pharmaceutical manufacturing, prewholesaling, distribution, healthcare information and retailing. A large part of the Group’s income is generated by international operations.

Contact Details: Corporate CommunicationsUntermattweg 8 Berne CH-3027 Tel: 41 58 852 85 17 Fax: 41 58 852 85 58 Email: info@galenica.com WWW: www.galenica.ch/

Recent Publications by Galenica Ltd.:
Drug release from lipid liquid crystalline phases: relation with phase behavior. Introduction: We studied the release of propranolol hydrochloride (PHCl),...	24th October, 2009	Centro de Estudos Farmaceuticos, Laboratorio de Galenica e Tecnologia	Drug Dev Ind Pharm. 2009 Oct 22. DOI Direct Link
Conformational stability of ibuprofen: assessed by DFT calculations and optical vibrational spectroscopy. A thorough conformational analysis of ibuprofen [2-(4-isobutylphenyl)...	4th April, 2008	Centro de Estudos Farmaceuticos, Laboratorio de Galenica e Tecnologia	J Pharm Sci. 2008 Feb;97(2):845-59. DOI Direct Link
Influence of cellulose ether mixtures on ibuprofen release: MC25, HPC and HPMC K100M. The influence of cellulose ether derivatives on ibuprofen release from...	20th October, 2006	Centro de Estudos Farmaceuticos, Laboratorio de Galenica e Tecnologia	Pharm Dev Technol. 2006;11(2):213-28. DOI Direct Link
Role of cellulose ether polymers on ibuprofen release from matrix tablets. Cellulose derivatives are the most frequently used polymers in...	6th July, 2006	Centro de Estudos Farmaceuticos (CEF), Laboratorio de Galenica e	Drug Dev Ind Pharm. 2005 Aug;31(7):653-65. DOI Direct Link
Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy. A conformational study of ketoprofen was carried out by both density...	14th April, 2006	Centro de Estudos Farmaceuticos (CEF), Laboratorio de Galenica e	Int J Pharm. 2006 Jan 3;307(1):56-65. Epub 2005 Nov 4. DOI Direct Link
→View more Galenica Ltd. research publications.

BioNews Results for Galenica Ltd.:
MIGENIX Appoints Chief Executive Officer	Individual.com:  Oct 22 2009 12:32PM Matching: galenica
10:59 - Bulgaria: Sopharma revenues seen 30% lower in 2009	Reporter.gr:  Oct 22 2009 10:08AM Matching: galenica
Bulgaria: Sopharma revenues seen 30% lower in 2009	Reporter.gr:  Oct 22 2009 9:37AM Matching: galenica
Galenica acquires Swiss company Om Pharma	PharmaBiz:  Sep 9 2009 4:26PM Matching: galenica
XSpray Launches GMP Production Facility	Pharmaceutical Business Review:  Aug 24 2009 10:02AM Matching: galenica
Promote your company here: BioNewsCast - Press Release Distribution	→View more Galenica Ltd. news.

Galenica Ltd. Patents:
US Patent No.	Title
6960344	Use of imine-forming polysaccharides as adjuvants and immunostimulants
6573245	Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
6262029	Chemically modified saponins and the use thereof as adjuvants
6080725	Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
5977081	Triterpene saponin analogs having adjuvant and immunostimulatory activity
→View more Galenica Ltd. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 313 times since April 2007, the link to the organisation's website has been followed 50 times

Search for more companies in Berne

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Galenica Ltd.